Friday, November 1, 2024
HomeIndustriesBiotechnology

Biotechnology

Actinium Appoints Lynn Bodarky as Chief Business Officer

Actinium Pharmaceuticals, Inc., a leader in the development of targeted radiotherapies, announced that Lynn Bodarky has been named Chief Business Officer to lead the Company's...

Read Magazine’s Weekly Roundup: Discover the Most Recent News From Opus IVS, Glia, Grow-NY, Lummus Technology, Codagenix !

Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...

Microbes, Mucus, and Brain Organoids–Experiments to Prevent and Treat Disease Launching on Next Space Station Resupply Mission

From research on microbes to studies on brain organoids, a new pharmaceutical lab, and the role of mucus in medication delivery, several payloads launching on SpaceX's...

Codagenix Announces Presentation of Updated Preclinical CodaLytic™ Data at Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

Codagenix Inc., a clinical-stage synthetic biology company with a rational virus design platform for viral vaccines and immuno-oncology therapeutics, announced the presentation of preclinical...

Triumvira Immunologics Announces First Patient Dosed in Phase II of TACTIC-2 Cell Therapy Trial for the Treatment of HER2+ Gastric and GEJ Cancers

Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat...
0FansLike
0FollowersFollow
spot_img

Hot Topics